Literature DB >> 3126381

A cost-effectiveness analysis of alternative strategies for the prevention of heart disease.

J P Hall1, R F Heller, A J Dobson, D M Lloyd, R W Sanson-Fisher, S R Leeder.   

Abstract

The identification of risk factors, such as a raised cholesterol level, hypertension, cigarette smoking, and obesity, permits the prediction of the possible development of ischaemic heart disease and has led to attempts at its prevention through modification of these factors. A high risk of developing ischaemic heart disease is also associated with age, specific socioeconomic groups, a family history of ischaemic heart disease, and preexisting evidence of the disease. Preventive strategies have either sought to reduce the average levels of risk in the general population or to identify by population screening individuals or groups who are at particular risk and to reduce their level of risk. Differing methods of risk-factor identification and modification are appropriate for each of the high-risk groups. For a number of strategies that are directed at either the whole population or high-risk groups we have estimated the costs of identification and risk-factor modification and the probable benefits of undertaking such a strategy. A strategy which educates the whole population by way of the media costs considerably less than does any strategy that involves the identification of individuals at high risk. At a medium cost estimate, with a reduction in risk of only 1%, such an approach costs approximately $8000 per case that is prevented; when risk reduction approaches 3% it actually results in a saving of health-care expenditure within five years. The costs of the other strategies vary between $12,000 and $26,000 per case that is prevented in a five-year period.

Entities:  

Mesh:

Year:  1988        PMID: 3126381     DOI: 10.5694/j.1326-5377.1988.tb117833.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  7 in total

Review 1.  Resource utilisation in the management of dyslipidaemia.

Authors:  T D Szucs
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 2.  The economics of smoking: an overview of the international and New Zealand literature.

Authors:  D Phillips; I Kawachi; M Tilyard
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

3.  Prospects for preventing heart disease.

Authors:  S Leeder; M Gliksman
Journal:  BMJ       Date:  1990-11-03

4.  Death of a heart surgeon: reflections on press accounts of the murder of Victor Chang.

Authors:  D Lupton; S Chapman
Journal:  BMJ       Date:  1991 Dec 21-28

5.  A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease.

Authors:  S Kinlay; D O'Connell; D Evans; J Halliday
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

Review 6.  Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.

Authors:  T van der Weijden; J A Knottnerus; A J Ament; H E Stoffers; R P Grol
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

Review 7.  Cost-effective intervention in stroke.

Authors:  D Dunbabin
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.